Taiwan's Academic Sinica has synthesized monoclonal antibodies that are able to identify the protein of SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), an important step in the direction of producing a rapid screening reagent for the fast spreading pathogenic virus.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
U.S. dollar closes higher on Taipei forex market
05/12/2025 04:18 PM - Politics
'De-Han-ification'? Executive Yuan webpage edit sparks controversy
05/12/2025 04:07 PM - Business
TSMC ranked as No. 10 most valuable company globally in 2025
05/12/2025 03:38 PM - Society
Taiwan asks foreigners to take road safety survey
05/12/2025 03:17 PM - Cross-Strait
2 holders of Chinese ID cards found in Taiwan's public service: MAC
05/12/2025 02:18 PM